Show simple item record

dc.contributor.authorSchoellhammer, Carl Magnus
dc.contributor.authorBlankschtein, Daniel
dc.contributor.authorLanger, Robert
dc.date.accessioned2014-10-29T20:10:53Z
dc.date.available2014-10-29T20:10:53Z
dc.date.issued2014-03
dc.identifier.issn1742-5247
dc.identifier.issn1744-7593
dc.identifier.urihttp://hdl.handle.net/1721.1/91233
dc.description.abstractIntroduction: Transdermal delivery has potential advantages over other routes of administration. It could reduce first-pass metabolism associated with oral delivery and is less painful than injections. However, the outermost layer of the skin, the stratum corneum (SC), limits passive diffusion to small lipophilic molecules. Therefore, methods are needed to safely permeabilize the SC so that ionic and larger molecules may be delivered transdermally. Areas covered: This review focuses on low-frequency sonophoresis, microneedles, electroporation and iontophoresis, and combinations of these methods to permeabilize the SC. The mechanisms of enhancements and developments in the last 5 years are discussed. Potentially high-impact applications, including protein delivery, vaccination and sensing are presented. Finally, commercial interest and clinical trials are discussed. Expert opinion: Not all permeabilization methods are appropriate for all applications. Focused studies into applications utilizing the advantages of each method are needed. The total dose and kinetics of delivery must be considered. Vaccination is one application where permeabilization methods could make an impact. Protein delivery and analyte sensing are also areas of potential impact, although the amount of material that can be delivered (or extracted) is of critical importance. Additional work on the miniaturization of these technologies will help to increase commercial interest.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (NIH grant EB-00351)en_US
dc.language.isoen_US
dc.publisherInforma UK (Informa Healthcare)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1517/17425247.2014.875528en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleSkin permeabilization for transdermal drug delivery: recent advances and future prospectsen_US
dc.typeArticleen_US
dc.identifier.citationSchoellhammer, Carl M, Daniel Blankschtein, and Robert Langer. “Skin Permeabilization for Transdermal Drug Delivery: Recent Advances and Future Prospects.” Expert Opin. Drug Deliv. 11, no. 3 (March 2014): 393–407.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Chemical Engineeringen_US
dc.contributor.mitauthorSchoellhammer, Carl Magnusen_US
dc.contributor.mitauthorBlankschtein, Danielen_US
dc.contributor.mitauthorLanger, Roberten_US
dc.relation.journalExpert Opinion on Drug Deliveryen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsSchoellhammer, Carl M; Blankschtein, Daniel; Langer, Roberten_US
dc.identifier.orcidhttps://orcid.org/0000-0001-6694-6761
dc.identifier.orcidhttps://orcid.org/0000-0002-7836-415X
dc.identifier.orcidhttps://orcid.org/0000-0003-4255-0492
mit.licenseOPEN_ACCESS_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record